You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Patent: 6,022,539

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,022,539
Title: Amelioration of peyronie\'s disease
Abstract:A method of treating an individual suffering from Peyronie\'s disease. Collagenase is injected into a fibrous Peyronie\'s plaque in the penis of the individual suffering from the disease. The penis immediately after injection, is immobilized and maintained immobile for several hours. The collagenase is in a pharmaceutically acceptable carrier in a concentration of about 20,000 to about 40,000 ABC units per ml., and the amount and concentration of the collagenase is effective to soften and/or rupture the plaque whereby the erectile deviation caused by the plaque is ameliorated
Inventor(s): Wegman; Thomas L. (North Merrick, NY)
Assignee: Advance Biofactures of Curacao (Curacao, AN)
Application Number:09/325,224
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,022,539
Patent Claims:see list of patent claims

Details for Patent 6,022,539

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Advance Biofactures of Curacao (Curacao, AN) 2039-03-29 RX company
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Advance Biofactures of Curacao (Curacao, AN) 2039-03-29 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.